American Psychiatric Association. Somatic Symptom and Related Disorders. In: Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). American Psychiatric Publishing: Arlington, VA; 2022.
2.
HammadTA, LaughrenT, RacoosinJ. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry, 2006; 63(3):332–339.
3.
Juncal-RuizM, Ramirez-BonillaM, Gomez-ArnauJ, et al.Incidence and risk factors of acute akathisia in 493 individuals with first episode nonaffective psychosis: A 6-week randomised study of antipsychotic treatment. Psychopharmacology, 2017; 234:2563–2570.
4.
McCauleyE, BerkMS, AsarnowJR, et al.Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: A randomized clinical trial. JAMA Psychiatry, 2018; 75(8):777–785.
5.
O'ConnellN, NicholsonT, BlackmanG, et al.Medication prescriptions in 322 motor functional neurological disorder patients in a large UK mental health service: A case control study. Gen Hosp Psychiatry, 2019; 58:94–102.
6.
PagsbergAK, JeppesenP, KlauberDG, et al.Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: The multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry, 2017; 4(8):605–618.
7.
SachdevP, KrukJ. Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry, 1994; 51:963–974.
8.
SørensenJØ, RasmussenA, RoesbjergT, et al.Suicidality and self-injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing. Acta Psychiatr Scand, 2022; 145(2):209–222.
9.
StoneJ, SmythR, CarsonA, et al.Systematic review of misdiagnosis of conversion symptoms and “hysteria”. BMJ, 2005; 331(7523):989.
10.
StroupTS, GrayN. Management of common adverse effects of antipsychotic medications. World Psychiatry, 2018; 17(3):341–356.
11.
StübnerS, GrohmannR, GreilW, et al.Suicidal ideation and suicidal behavior as rare adverse events of antidepressant medication: Current report from the AMSP multicenter drug safety surveillance project. Int J Neuropsychopharmacol, 2018; 21(9):814–821.
12.
WohlfarthTD, van ZwietenBJ, LekkerkerkerFJ, et al.Antidepressants use in children and adolescents and the risk of suicide. Eur Neuropsychopharmacol, 2006; 16(2):79–83